QIVIX Fees and Costs — Invesco International Equity Fund, Class R6
Data updated: 2023-06-29
The net expense ratio is 0.84%: a 0.77% management fee plus 0.07% other expenses, less a 0.01% fee waiver. There are no sales loads or redemption fees. In fiscal 2022 the fund paid $2.3M in broker commissions, 0.2021% of average net assets, and portfolio turnover was 107%.
QIVIX Fees and Expenses
Annual operating expenses and sales charges of QIVIX. Prospectus, as of October 31, 2022.
| Annual operating expenses | |
|---|---|
| Management fee | 0.77% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.07% |
| Gross expense ratio | 0.85% |
| Fee waiver | −0.01% |
| Net expense ratio | 0.84% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
QIVIX Costs Over Time
On $10,000 invested in QIVIX, assuming 5% a year before costs, total costs come to $651 over 5 years, cutting the return by 1.09% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.84%) | $88 | $275 | $477 |
| Trading costs (broker commissions) | $21 | $66 | $115 |
| Lost growth on money paid in costs | $0 | $17 | $60 |
| Total costs | $109 | $358 | $651 |
| Value after costs | $10,391 | $11,218 | $12,112 |
| Impact on return, per year | 1.09% | 1.09% | 1.09% |
QIVIX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2022.
- Explicit cost rate (commissions ÷ average net assets): 0.2021%
- Total broker commissions: $2.3M
- Bought from dealers (principal trades, not a cost): $34.5M
- Portfolio turnover (prospectus): 107%
- Securities on loan, average value: $648K
- Net income from securities lending: $3K (0.000% of average net assets)
QIVIX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| UBS SECURITIES LLC | $235K | 13.71% |
| MORGAN STANLEY & CO. LLC | $206K | 11.99% |
| GOLDMAN, SACHS & CO. | $200K | 11.64% |
| CREDIT SUISSE SECURITIES (USA) LLC | $199K | 11.62% |
| MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | $193K | 11.26% |
| JEFFERIES LLC | $164K | 9.55% |
| CITIGROUP GLOBAL MARKETS INC. | $147K | 8.55% |
| J.P. MORGAN SECURITIES LLC | $144K | 8.37% |
| HSBC SECURITIES (USA) INC. | $119K | 6.96% |
| BARCLAYS CAPITAL INC. | $109K | 6.36% |
QIVIX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | $18.1M | 52.53% |
| J.P. MORGAN SECURITIES LLC | $16.4M | 47.47% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.